The pharmacokinetics of intravenous ketorolac in children aged 2 months to 16 years: A population analysis
Authors:
- James S. McLayJMJames S. McLay
- Thomas EngelhardtTEThomas Engelhardt
- Baba S. MohammedBMBaba S. Mohammed
- Gary CameronGCGary Cameron
- Jeffrey L. GalinkinJGJeffrey L. Galinkin
- Uwe ChristiansUwe Christians
- Michael J. AvramMAMichael J. Avram
- Thomas K. HenthornTHThomas K. Henthorn
- Ahmed F. HawwaAHAhmed F. Hawwa
- Brian J. AndersonBABrian J. Anderson
- 21 December 2017
- journal article
- research article
- Published by Wiley in Pediatric Anesthesia
- Vol. 28 (2) , 80-86
Abstract
Summary: Background: Intravenous ketorolac is commonly administered to children for the control of postoperative pain. An effect siteEC50for analgesia of 0.37 mg.L−1is described in adults.Aims: The aim of this study was to review age‐ and weight‐related effects on ketorolac pharmacokinetic parameters in children and current dosing schedules.Methods: Pooled intravenous ketorolac (0.5 mg.kg−1) concentration‐time data in children aged 2 months to 16 years were analyzed using nonlinear mixed‐effects models. Allometry was used to scale to a 70 kg person.Results: There were 64 children aged 2 months to 16 years (641 plasma concentrations) available for analysis. A two‐compartment mammillary model was used to describe pharmacokinetics. Clearance was 2.53 (CV45.9%) L.h−1.70 kg−1and intercompartment clearance was 4.43 (CV95.6%) L.h−1.70 kg−1. Both central (V1) and peripheral (V2) volumes of distribution decreased with age over the first few years of postnatal life to reach V1 6.89 (CV30.3%) L.70 kg−1and V2 5.53 (CV47.6%) L.70 kg−1.Conclusion: Clearance, expressed as L.h−1.kg−1, decreased with age from infancy. A dosing regimen of 0.5 mg.kg−1every 6 hours maintains a trough concentration larger than 0.37 mg.L−1in children 9 months to 16 years of age. This dosing regimen is consistent with current recommendations.Keywords
Funding Information
- institutional resources
This publication has 37 references indexed in Scilit:
- Pharmacokinetics of Single-Dose Intravenous Ketorolac in Infants Aged 2–11 MonthsAnesthesia & Analgesia, 2011
- Microassay of drugs and modern measurement techniquesPediatric Anesthesia, 2011
- Ketorolac tromethamine: stereo‐specific pharmacokinetics and single‐dose use in postoperative infants aged 2–6 monthsPediatric Anesthesia, 2010
- Population pharmacokinetic analysis of varenicline in adult smokersBritish Journal of Clinical Pharmacology, 2009
- Dexmedetomidine pharmacokinetics in pediatric intensive care – a pooled analysisPediatric Anesthesia, 2009
- Human renal function maturation: a quantitative description using weight and postmenstrual agePediatric Nephrology, 2009
- Problems and pitfalls performing pharmacokinetic studies in childrenPaediatric and Perinatal Drug Therapy, 2007
- Injected Morphine in Postoperative PainJournal of Pain and Symptom Management, 1999
- Chiral Kinetics and Dynamics of KetorolacThe Journal of Clinical Pharmacology, 1996
- A Size Standard for PharmacokineticsClinical Pharmacokinetics, 1996